The Latest Breaking News from CMS

What Changed in Remote Therapeutic Monitoring in 2026?

The Centers for Medicare & Medicaid Services completely rewired Remote Therapeutic Monitoring for physical therapists and healthcare systems. The biggest news is that CMS finalized lower data collection and management thresholds to bridge real-world clinical gaps for shorter duration monitoring. Historically, the rigid 16-day monitoring requirement caused widespread billing friction…

inkl · May 25

Projected 2027 IRMAA Brackets and Surcharges for Medicare Part B and D

Will you owe the Medicare IRMAA surcharge in 2027? Grab your 2025 tax return and check the projected brackets and surcharges for next year.

Kiplinger · May 25

CorMedix Eyes REZZAYO Expansion as DefenCath Reimbursement Shift Looms

CorMedix (NASDAQ:CRMD) CEO Joe said the company is preparing for several potential commercial and regulatory catalysts across its infectious disease and dialysis-related portfolio, including a possible expansion of REZZAYO into fungal infection prophylaxis and continued work to sustain DefenCath uti

MarketBeat · May 22

GRAIL Says Galleri Demand Is Rising as NHS Talks, FDA Review Move Ahead

GRAIL (NASDAQ:GRAL) said demand for its Galleri multi-cancer early detection test has continued to grow despite recent headlines related to its NHS study, according to comments made by Aaron, who identified himself during the discussion as the company’s CFO, at a Bank of America event. Aaron said t

MarketBeat · May 17

CMS’s New AI-Powered Prior Authorization System: Will It Speed Up Approvals or Deny Seniors Critical Care?

For years, seniors and doctors have complained that prior authorization delays can feel like a second illness layered on top of an existing medical problem....

Saving Advice · May 17

Weight-Loss Drugs Wegovy & Foundayo Get Medicare Coverage on July 1, 2026 — Find Out Who Qualifies

For years, many older Americans watched popular weight-loss drugs like Wegovy stay financially out of reach because Medicare would not cover medications prescribed mainly for...

Saving Advice · May 16

DocGo Targets Profitability as It Pivots to Mobile Health, Medical Transport

DocGo (NASDAQ:DCGO) Chief Executive Officer Lee Bienstock outlined the company’s transition away from COVID-related, migrant and emergency-response programs and toward its “evergreen” medical transportation and mobile health businesses during a presentation at the 21st Annual Needham Technology, Med

MarketBeat · May 16

Medicare’s 72-Hour Decision Rule Begins Now: What Seniors Must Know About Faster Approvals and Denials

Millions of seniors enrolled in Medicare Advantage plans have spent years frustrated by delayed prior authorization decisions for medical care, scans, procedures, and treatments. Some...

Saving Advice · May 16

Vance’s Medicare crackdown just froze billions in hospice care, but the scheme it uncovered is far darker than a simple billing scam

Vice President J.D. Vance’s Medicare fraud task force just froze billions in hospice care payments, slamming the brakes on new providers nationwide for the next six months. The move, announced on May 13, 2026, is the sharpest crackdown yet on what officials are calling a crisis of exploitation — one…

The Mary Sue · May 14

AxoGen Says Nerve Repair Strategy Intact as Reimbursement Wins Gather Steam

AxoGen (NASDAQ:AXGN) President and CEO Michael Dale said the company’s growth strategy remains centered on developing the market for peripheral nerve repair, while recent reimbursement wins are expected to be positive but have not yet been quantified. Speaking during a company event, Dale said he w

MarketBeat · May 14